Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
6.14
+0.18 (3.02%)
Mar 4, 2026, 4:00 PM EST - Market closed
Solid Biosciences Market Cap
Solid Biosciences has a market cap or net worth of $478.37 million as of March 4, 2026. Its market cap has increased by 197.12% in one year.
Market Cap
478.37M
Enterprise Value
264.16M
1-Year Change
197.12%
Ranking
Category
Stock Price
$6.14
Market Cap Chart
Since January 26, 2018, Solid Biosciences's market cap has decreased from $754.10M to $478.37M, a decrease of -36.56%. That is a compound annual growth rate of -5.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 464.30M | 5.67% |
| Dec 31, 2025 | 439.40M | 174.97% |
| Dec 31, 2024 | 159.80M | 28.97% |
| Dec 29, 2023 | 123.90M | 205.93% |
| Dec 30, 2022 | 40.50M | -79.02% |
| Dec 31, 2021 | 193.00M | -57.88% |
| Dec 31, 2020 | 458.20M | 123.95% |
| Dec 31, 2019 | 204.60M | -78.45% |
| Dec 31, 2018 | 949.60M | 25.92% |
| Jan 26, 2018 | 754.10M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zevra Therapeutics | 511.74M |
| Prothena Corporation | 506.03M |
| Eupraxia Pharmaceuticals | 498.56M |
| Kyverna Therapeutics | 486.17M |
| Invivyd | 485.02M |
| Vanda Pharmaceuticals | 482.91M |
| 4D Molecular Therapeutics | 475.90M |
| Lineage Cell Therapeutics | 472.54M |